Urologix, Inc. (ULGX)
F4Q2010 Earnings Call Transcript
August 24, 2010 5:00 pm ET
Stryker Warren – CEO
Brian Smrdel – CFO
Greg Fluet – EVP & COO
Ernest Andberg – Feltl and Company
Good day, ladies and gentlemen. Welcome to the Urologix Incorporated Fiscal Year 2010 and Fourth Quarter Conference Call. My name is Keith, and I will be your coordinator for today. At this time, all participants and in a listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. As a reminder, this conference is being recorded for replay purposes.
Statements made at this presentation may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected in any forward-looking statements due to risks and uncertainties. A detailed discussion of risks and uncertainties maybe found in Urologix's recent Annual Report on Form 10-K for the year ended June 30th, 2009, and other documents filed with the Securities and Exchange Commission.
At this time, I will turn the call over to Mr. Stryker Warren, Jr., Chief Executive Officer. Please proceed, sir.
Good afternoon. This is Stryker Warren. As Chief Executive Officer of Urologix, I welcome you to this earnings call. Joining me are Brian Smrdel, Urologix's Chief Financial Officer; and Greg Fluet, Urologix's Executive Vice President and Chief Operating Officer.
Before I share my perspective on the fourth quarter and full year of fiscal 2010, I will ask Brian to review the financial results.